The Alabama Department of Public Health is working with other health agencies to investigate an injectable anti-inflammatory drug prepared by a compounding manufacturer in Tennessee.
Main Street Family Pharmacy of Newbern, Tenn. shipped the tainted medicine to clinics in 13 states.
The investigation began after the U.S. Food and Drug Administration was notified of seven people who developed infections or adverse reactions after receiving injections of methylprednisolone acetate (MPA). It’s the same drug that was linked to last year’s deadly outbreak of fungal meningitis.
The investigation is in an early stage and is rapidly evolving, according to Dr. Mary McIntyre of the ADPH.
Was this article valuable?
Here are more articles you may enjoy.
Toyota Executive Lashes Out at US Regulations Promoting EV Sales 
NSA Director Wants Industry to Disclose Details of Telecom Hacks 
US Charges Five in ‘Scattered Spider’ Hacking Scheme 
What’s Behind New York Fires? Climate Change, Land Use and History 
Want to stay up to date?
Get the latest insurance news
sent straight to your inbox.